Memphis Pharmaceutical approves estimated budget for FY 2023/24

It is worth noting that the company has reported a 67% annual surge in its net profits after tax in the first nine months of FY 2022/2023

Staff Writer, Arab Finance

July 20, 2023

PHOTO

Memphis Pharmaceutical and Chemical Industries’ board has approved the estimated budget for the fiscal year (FY) 2023/2024 with expected net profits after tax of EGP 104.200 million, according to a filing on July 19th.

The company is also targeting revenues of EGP 816 million.

It is worth noting that the company has reported a 67% annual surge in its net profits after tax in the first nine months of FY 2022/2023.

Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

ZAWYA NEWSLETTERS

RELATED ARTICLES

ZAWYA NEWSLETTERS

LATEST VIDEO